PATENT CLAIM ANALYSIS

Application Number: 15875929
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["548", "537000"]

Abstract:
Inhibitors of HBV replication of Formula (ID) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R a  to R d  and R 4  to R 6  have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.

Claim (Index 23):
The method of  claim 22 , wherein the conditions associated with HBV infection are selected from the group consisting of liver fibrosis, liver inflammation, liver necrosis, cirrhosis, end-stage liver disease, and hepatocellular carcinoma.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 548.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14891895', '14907109', '15031493', '14782308', '15177641']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8322428795720234
- 35 USC 102 Novelty (BERT): 0.547317557094749
- Combined Prediction Score: 0.803750347324296
- Mean Citation Score: 401.944878
- Max Citation Score: 458.7033
- Similarity Product: 280.10473816570044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test